Table 3.
Parameter | Unstandardized coefficient B | Standard error | Wald | Odds ratio (95% confidence interval) | P-value |
---|---|---|---|---|---|
Age | 0.016 | 0.004 | 17.895 | 1.016 (1.009–1.024) | <0.001 |
Left ventricular ejection fraction | −0.010 | 0.007 | 2.179 | 0.990 (0.978–1.003) | 0.140 |
Previous percutaneous coronary intervention | −0.179 | 0.097 | 3.383 | 0.836 (0.691–1.012) | 0.066 |
Rheumatic heart disease | −0.604 | 0.264 | 5.236 | 0.546 (0.326–0.917) | 0.022 |
Beta blockera | −0.202 | 0.109 | 3.423 | 0.817 (0.660–1.012) | 0.064 |
Angiotensin-converting enzyme inhibitora | −0.008 | 0.088 | 0.008 | 0.992 (0.835–1.179) | 0.927 |
Loop diuretica | 0.323 | 0.121 | 7.088 | 1.382 (1.089–1.753) | 0.008 |
Antiarrhythmic druga | 0.222 | 0.117 | 3.608 | 1.248 (0.993–1.569) | 0.057 |
Ivabradinea | 0.228 | 0.105 | 4.727 | 1.256 (1.023–1.542) | 0.03 |
Statina | −0.109 | 0.115 | 0.901 | 0.896 (0.715–1.123) | 0.343 |
Digoxina | 0.316 | 0.172 | 3.362 | 1.372 (0.978–1.922) | 0.067 |
Hemoglobin | 0.015 | 0.022 | 0.432 | 1.015 (0.971–1.060) | 0.511 |
Serum creatinine | 0.266 | 0.048 | 30.343 | 1.305 (1.187–1.434) | <0.001 |
Constant | −2.966 | 0.485 | 37.456 | 0.052 | <0.001 |
Bold values in P-value column indicate statistically significant differences.
The medication details represent treatment advise provided at the clinic, and it is not known whether these medications were continued as advised, changed, or stopped during the subsequent one year.